Polatuzumab

3 Cited Publications
Kundenbewertung

Based on 3 publication(s) in Google Scholar

Polatuzumab is a monoclonal antibody that targets CD79b on the surface of B cells. Polatuzumab can be used to synthesize the ADC Polatuzumab Vedotin (HY-132253), which has anti-tumor activity.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.69%
  • CAS. Nr.: 2279068-37-8
  • Molecular Weight:145.5 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00